{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:23:05Z","timestamp":1787840585096,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Metabolic-dysfunction-associated steatotic liver disease (MASLD) is increasingly affecting younger populations worldwide, yet early-phase data from low-risk, health-literate groups remain limited. This study aimed to evaluate temporal changes in the prevalence and risk factors of hepatic steatosis among medical students across two cohorts 6 years apart.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      We enrolled 489 medical students from King Saud University across two cross-sectional cohorts (2017:\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 301; 2023:\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      = 188). All underwent noninvasive liver assessment using transient elastography (FibroScan\u00ae, controlled attenuation parameter [CAP] \u2265248 dB\/m indicating steatosis). Demographic, anthropometric, and lifestyle data were collected via standardized questionnaires. Logistic regression identified independent steatosis predictors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The overall prevalence of hepatic steatosis was 21.1%, increasing from 18.6% in 2017 to 25.0% in 2023 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.092). Students with steatosis had significantly higher BMI, waist circumference, and obesity prevalence (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Advanced fibrosis (\u2265F2) was rare (1.6%). Male sex and central adiposity were strongly associated with steatosis. In the 2023 cohort, strength training was less common among those with steatosis (34.8% vs 69.4%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002). Frequent fast-food intake and reduced consumption of antioxidant-rich foods were associated with steatosis in univariable analysis but lost significance after adjustment. A self-reported history of fatty liver remained the only independent predictor (adjusted OR = 6.28; 95% CI: 1.14\u201347.8;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.042).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This cross-sectional comparative study of two medical student cohorts, 6 years apart, reveals a rising prevalence of hepatic steatosis among young adults. Despite low rates of advanced fibrosis, many showed early metabolic risk markers. These findings highlight the need for early screening and preventive strategies targeting youth at risk for MASLD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_484_25","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T14:00:53Z","timestamp":1773842453000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Temporal trends in hepatic steatosis and its risk factors among young adults: A comparative cohort study"],"prefix":"10.4103","author":[{"given":"Abdullah M.","family":"Alsaeed","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaida","family":"AlMasaad","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Security Forces Hospital, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf M.","family":"Alharbi","sequence":"additional","affiliation":[{"name":"Department of Radiology, King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenah","family":"AlAseem","sequence":"additional","affiliation":[{"name":"Family Medicine, Ministry of Health, Prince Sultan Military Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema F.","family":"AlRashed","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeed M.","family":"Al Rashoud","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakan A.","family":"Aldoghmani","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norah","family":"Alkathiri","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Saud University Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazeed","family":"Alsulaim","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled B.","family":"AlSulaim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, King Fahad Medical City, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saud M.","family":"Alshahrani","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, King Saud University, Armed Forces Hospital Southern Region (AFHSR), Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Almufarriji","sequence":"additional","affiliation":[{"name":"Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maram","family":"Alkhammash","sequence":"additional","affiliation":[{"name":"Liver Disease Research Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal M.","family":"Sanai","sequence":"additional","affiliation":[{"name":"Gastroenterology Section, Department of Medicine, King Abdulaziz Medical City, King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs, Jeddah, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed","family":"Al Hamoudi","sequence":"additional","affiliation":[{"name":"Liver Disease Research Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid A.","family":"Alswat","sequence":"additional","affiliation":[{"name":"Liver Disease Research Center, Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"R1-20260318","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): A systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"R2-20260318","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"R3-20260318","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S2468-1253(20)30213-2","article-title":"Nomenclature and definition of metabolic-associated fatty liver disease: A consensus from the Middle East and North Africa","volume":"6","author":"Shiha","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R4-20260318","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cld.2023.01.014","article-title":"Nonalcoholic fatty liver disease in Asia, Africa, and Middle East region","volume":"27","author":"Ong","year":"2023","journal-title":"Clin Liver Dis"},{"key":"R5-20260318","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/liv.15852","article-title":"Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa","volume":"44","author":"Younossi","year":"2024","journal-title":"Liver Int"},{"key":"R6-20260318","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden: Saudi Arabia and United Arab Emirates, 2017\u20132030","volume":"24","author":"Alswat","year":"2018","journal-title":"Saudi J Gastroenterol"},{"key":"R7-20260318","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12902-018-0244-4","article-title":"Prevalence of metabolic syndrome in Saudi Arabia: A cross-sectional study","volume":"18","author":"Al-Rubeaan","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"R8-20260318","doi-asserted-by":"crossref","first-page":"973","DOI":"10.15537\/smj.2023.44.10.20230450","article-title":"Understanding the prevalence, progression, and management of metabolic syndrome in Saudi Arabia","volume":"44","author":"Alshehri","year":"2023","journal-title":"Saudi Med J"},{"key":"R9-20260318","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J Hepatol"},{"key":"R10-20260318","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2018-317593","article-title":"Advances in non-invasive assessment of hepatic fibrosis","volume":"69","author":"Loomba","year":"2020","journal-title":"Gut"},{"key":"R11-20260318","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1053\/j.gastro.2023.06.013","article-title":"AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: Expert review","volume":"165","author":"Wattacheril","year":"2023","journal-title":"Gastroenterology"},{"key":"R12-20260318","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1097\/MEG.0000000000000681","article-title":"Prevalence of hepatic steatosis in apparently healthy medical students: A transient elastography study on the basis of a controlled attenuation parameter","volume":"28","author":"Kaya","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R13-20260318","first-page":"111","article-title":"The prevalence of non-alcoholic fatty liver disease in healthy young persons","volume":"3","author":"Okur","year":"2016","journal-title":"North Clin Istanb"},{"key":"R14-20260318","doi-asserted-by":"crossref","first-page":"1431935","DOI":"10.3389\/fmed.2024.1431935","article-title":"Predicting cardiometabolic disease in medical students using FibroScan and 30-year Framingham risk scores","volume":"11","author":"Sharma","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"R15-20260318","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD);European Association for the Study of Obesity (EASO) EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"R16-20260318","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"European Association for the Study of the Liver;Asociacion Latinoamericana para el Estudio del Higado; EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"R17-20260318","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/hep.29068","article-title":"Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic","volume":"65","author":"Doycheva","year":"2017","journal-title":"Hepatology"},{"key":"R18-20260318","doi-asserted-by":"crossref","first-page":"1326418","DOI":"10.3389\/fpubh.2023.1326418","article-title":"Dietary trends and obesity in Saudi Arabia","volume":"11","author":"Alhusseini","year":"2023","journal-title":"Front Public Health"},{"key":"R19-20260318","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/HEP.0000000000000383","article-title":"Global and national prevalence of nonalcoholic fatty liver disease in adolescents: Analysis of the Global Burden of Disease Study 2019","volume":"78","author":"Hartmann","year":"2023","journal-title":"Hepatology"},{"key":"R20-20260318","first-page":"441","article-title":"Obesity: An emerging problem in Saudi Arabia","volume":"13","author":"Al-Othaimeen","year":"2007","journal-title":"Analysis of data from the National Nutrition Survey. East Mediterr Health J"},{"key":"R21-20260318","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4103\/ATMR.ATMR_78_24","article-title":"Non-alcoholic fatty liver disease prevalence and its relationship with obesity and metabolic health in Saudi adults: Findings from a cross-sectional study","volume":"1","author":"Alkathem","year":"2024","journal-title":"J Adv Trends Med Res"},{"key":"R22-20260318","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12876-024-03303-x","article-title":"Association between different obesity patterns and the risk of NAFLD detected by transient elastography: A cross-sectional study","volume":"24","author":"Sun","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R23-20260318","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jhep.2014.11.034","article-title":"Evidence of NAFLD progression from steatosis to fibrosing steatohepatitis using paired biopsies: Implications for prognosis and clinical management","volume":"62","author":"McPherson","year":"2015","journal-title":"J Hepatol"},{"key":"R24-20260318","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: State of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"R25-20260318","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cgh.2020.04.067","article-title":"Women have a lower risk of nonalcoholic fatty liver disease but a higher risk of progression vs men: A systematic review and meta-analysis","volume":"19","author":"Balakrishnan","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R26-20260318","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-J\u00e4rvinen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R27-20260318","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_484_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T13:25:30Z","timestamp":1787837130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_484_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":27,"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_484_25","relation":{},"ISSN":["1319-3767","1998-4049"],"issn-type":[{"value":"1319-3767","type":"print"},{"value":"1998-4049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"2025-12-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}